doi.org/10.1093/annonc/mdy281.021, hdl.handle.net/1765/125529
Annals of Oncology
Erasmus MC Cancer Institute

de Man, F., Hussaarts, K., de With, M. (M.), Oomen - de Hoop, E., van Halteren, H., van der Burg-De Graauw, N.C.H.P. (N. C.H.P.), … Mathijssen, R. (2018). Influence of the proton pump inhibitor esomeprazole on the bioavailability of regorafenib. Annals of Oncology, 29. doi:10.1093/annonc/mdy281.021